menu
    • menu

    Company profile for VectorBuilder

    NEW Drugs in Dev: 3
    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Egis is a Hungarian generic pharma company with 110 years history. Our activities incorporate all areas of the pharma value chain.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside.VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both rese...
    VectorBuilder is a global leader in gene delivery technologies. As a trusted partner for thousands of labs and biotech/pharma companies across the globe, VectorBuilder offers a full spectrum of gene delivery solutions covering virtually all research and clinical needs from bench to bedside.VectorBuilder is the future of gene delivery. Our mission is to provide end-to-end solutions for all gene delivery needs spanning both research and therapy. We strive to offer innovative and high-quality products and services while maintaining rapid turnaround and exceptional affordability.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    VectorBuilderUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1010 W 35th Street, Suite 515 Chicago, IL 60609
    Telephone
    Telephone
    800-517-2189
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://en.vectorbuilder.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/vectorbuilder/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    euroPLX 90 Lisbon

    Not Confirmed

    envelop Contact Supplier

    euroPLX 90 Lisbon

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Ikarovec Advances Intravitreal Pipeline via VectorBuilder Option
    Ikarovec Advances Intravitreal Pipeline via VectorBuilder Option

    06 Jan 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260106205147/en/Ikarovec-to-Advance-Pipeline-With-Exclusive-Worldwide-Option-to-VectorBuilders-Intravitreal-Capsid-Technology

    BUSINESSWIRE
    06 Jan 2026
    Share Share
    Vectorbuilder Redefines Plasmid Standards With Minivec
    Vectorbuilder Redefines Plasmid Standards With Minivec

    08 Oct 2025

    // INDPHARMAPOST

    https://www.indianpharmapost.com/rd/vectorbuilder-redefines-plasmid-standards-with-minivec-17964

    INDPHARMAPOST
    08 Oct 2025
    Share Share
    Vectorbuilder Secures Dual Imapac Awards In Gene Therapy
    Vectorbuilder Secures Dual Imapac Awards In Gene Therapy

    30 Sep 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250930786846/en/VectorBuilder-Wins-Two-IMAPAC-Awards-Cementing-Leadership-in-Gene-Therapy-and-CDMO-Innovation

    BUSINESSWIRE
    30 Sep 2025
    Share Share
    VectorBuilder Wins 2025 CDMO Award in CGT Global Category
    VectorBuilder Wins 2025 CDMO Award in CGT Global Category

    30 Apr 2025

    // PRESS RELEASE

    https://en.vectorbuilder.com/about-us/newsroom/vectorbuilder-honored-2025-cdmo-leadership-award.html

    PRESS RELEASE
    30 Apr 2025
    Share Share
    VectorBuilder Powers FDA IND For Cord Blood CAR-T Product
    VectorBuilder Powers FDA IND For Cord Blood CAR-T Product

    29 Jan 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250129313138/en

    BUSINESSWIRE
    29 Jan 2025
    Share Share
    GI Partners With VectorBuilder for Phase 3 HIV Vaccine Trials
    GI Partners With VectorBuilder for Phase 3 HIV Vaccine Trials

    03 Dec 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20241203503983/en

    BUSINESSWIRE
    03 Dec 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search